These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 21752148)
1. Which SPM method should be used to extract hippocampal measures in early Alzheimer's disease? Mevel K; Desgranges B; Baron JC; Landeau B; de La Sayette V; Viader F; Eustache F; Chételat G J Neuroimaging; 2011 Oct; 21(4):310-6. PubMed ID: 21752148 [TBL] [Abstract][Full Text] [Related]
2. Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches. Mevel K; Desgranges B; Baron JC; Landeau B; De la Sayette V; Viader F; Eustache F; Chételat G Neuroimage; 2007 Aug; 37(1):18-25. PubMed ID: 17566762 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of voxel-based morphometry with DARTEL and standard registration as imaging biomarkers in Alzheimer's disease patients and cognitively normal older adults at 3.0 Tesla MR imaging. Mak HK; Zhang Z; Yau KK; Zhang L; Chan Q; Chu LW J Alzheimers Dis; 2011; 23(4):655-64. PubMed ID: 21157022 [TBL] [Abstract][Full Text] [Related]
14. Comparison of regional gray matter volume abnormalities in Alzheimer׳s disease and late life depression with hippocampal atrophy using VSRAD analysis: a voxel-based morphometry study. Shimoda K; Kimura M; Yokota M; Okubo Y Psychiatry Res; 2015 Apr; 232(1):71-5. PubMed ID: 25773003 [TBL] [Abstract][Full Text] [Related]
15. Differences in cognitive ability and hippocampal volume between Alzheimer's disease, amnestic mild cognitive impairment, and healthy control groups, and their correlation. Choi MH; Kim HS; Gim SY; Kim WR; Mun KR; Tack GR; Lee B; Choi YC; Kim HJ; Hong SH; Lim DW; Chung SC Neurosci Lett; 2016 May; 620():115-20. PubMed ID: 27019036 [TBL] [Abstract][Full Text] [Related]
16. Harmonized benchmark labels of the hippocampus on magnetic resonance: the EADC-ADNI project. Bocchetta M; Boccardi M; Ganzola R; Apostolova LG; Preboske G; Wolf D; Ferrari C; Pasqualetti P; Robitaille N; Duchesne S; Jack CR; Frisoni GB; Alzheimers Dement; 2015 Feb; 11(2):151-60.e5. PubMed ID: 25223727 [TBL] [Abstract][Full Text] [Related]
17. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552 [TBL] [Abstract][Full Text] [Related]
18. Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI. Cantin S; Villien M; Moreaud O; Tropres I; Keignart S; Chipon E; Le Bas JF; Warnking J; Krainik A Neuroimage; 2011 Sep; 58(2):579-87. PubMed ID: 21745581 [TBL] [Abstract][Full Text] [Related]
19. DNA methylation in the NCAPH2/LMF2 promoter region is associated with hippocampal atrophy in Alzheimer's disease and amnesic mild cognitive impairment patients. Shinagawa S; Kobayashi N; Nagata T; Kusaka A; Yamada H; Kondo K; Nakayama K Neurosci Lett; 2016 Aug; 629():33-37. PubMed ID: 27356276 [TBL] [Abstract][Full Text] [Related]
20. How early can we predict Alzheimer's disease using computational anatomy? Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B; Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]